Body Composition, Functional Capacity, and Respiratory Muscle Endurance in Obesity With Restrictive Ventilatory Pattern

ConditionObesity
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age25-60
SponsorBiruni University

About this trial

This observational cross-sectional study aims to examine the relationship between body composition, functional capacity, and respiratory muscle endurance in individuals with obesity and a restrictive ventilatory pattern. A total of 100 adults aged 25-60 years with a body mass index (BMI) ≥30 kg/m² and restrictive pulmonary function findings will be enrolled. Participants will evaluate body composition assessment using bioelectrical impedance analysis, pulmonary function testing by spirometry, respiratory muscle strength and endurance measurements, and functional capacity evaluation using the Six-Minute Walk Test (6MWT). The aim of this study is to evaluate the relationships between stem cell count (SCC), a novel anthropometric indicator called WWI, trunk muscle mass, and functional capacity in obese individuals with a restrictive ventilatory pattern.

Eligibility criteria

Qualifiers

Individuals aged between 25 and 60 years

Individuals with a body mass index (BMI) ≥ 30 kg/m² according to the World Health Organization (WHO) classification

Individuals demonstrating a restrictive ventilatory pattern (FVC < 80% predicted)

Individuals who voluntarily agree to participate in the study

Disqualifiers

Individuals with a Charlson Comorbidity Index (CCI) score of 3 or higher

Individuals with uncontrolled arrhythmia, hypertension, heart failure, diabetes mellitus, or unstable angina pectoris

Individuals with cooperation impairments, orthopedic, or neurological conditions that may interfere with assessment or treatment

Individuals with a history of lower extremity injury or surgery within the last six months

Trial design

Treatments tested in this trial

  • Pulmonary Function, Body Composition, and Functional Capacity Assessment

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators